Lucira Health to Announce First Quarter 2021 Financial Results
Lucira Health, a medical technology company (Nasdaq: LHDX), will report its first-quarter financial results for the period ending March 31, 2021, on May 13, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Lucira Health, a medical technology company (Nasdaq: LHDX), will report its first-quarter financial results for the period ending March 31, 2021, on May 13, 2021. The management team will host a conference call at 1:30 p.m. PT / 4:30 p.m. ET to discuss the results and provide corporate updates. Lucira specializes in innovative infectious disease testing, offering products like the LUCIRA COVID-19 All-In-One Test Kit, which delivers results in 30 minutes. For more details, visit lucirahealth.com.
Positive
- Innovative product offering includes rapid COVID-19 testing kits.
- Management plans to provide a corporate update alongside the earnings call.
Negative
- None.
Details
News Market Reaction – LHDX
The recorded move for LHDX in the trading session of this news was -3.84%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
EMERYVILLE, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”) (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that the company will report first quarter ended March 31, 2021 financial results on Thursday, May 13, 2021. Lucira’s management will host a conference call and webcast at 1:30 p.m. PT / 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.
Conference Call and Webcast Details
The conference call can be accessed by dialing (833) 562-0151 for participants in the U.S. or Canada and (661) 567-1232 for international callers, using conference ID 3562914. A live and archived webcast of the event can be accessed via the Investors page of the investor section of Lucira's website.
About Lucira Health
Lucira Health is a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits. Lucira’s testing platform produces lab quality molecular testing in a single-use, consumer-friendly, palm size test kit powered by two AA batteries. Lucira designed its test kits to provide accurate, reliable and on-the-spot molecular tests results anywhere and anytime. The LUCIRA CHECK IT (OTC) and LUCIRA COVID-19 All-In-One Test Kits (RX) are designed to provide a clinically relevant COVID-19 result within 30 minutes from sample collection. For more information, visit www.lucirahealth.com.
Investor Contact
Greg Chodaczek
Investorrelations@lucirahealth.com
347-620-7010
Media Contact
Kevin Knight
media@lucirahealth.com
206-451-4823
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.